Researchers found that tirzepatide or Mounjaro reduced A1C levels by 2% to 2.3%, while Ozempic (1 mg) led to a 1.9% reduction
It is unknown whether Ozempic causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined
Remember, 6% of Ozempic users report fatigue, which may warrant earlier consultation
Absolutely, many people do, especially if progress stalls or convenience changes
Ozempic is primarily a medication for type 2 diabetes, and any off-label use for weight loss in non-diabetic individuals should be under strict medical supervision, with dosages being similar to those advised for diabetic patients looking to manage their weight